HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihito Yokoyama Selected Research

Carbonyl Reductase (NADPH)

10/2019Inhibitory effect of carbonyl reductase 1 against peritoneal progression of ovarian cancer: evaluation by ex vivo 3D-human peritoneal model.
12/2015Inhibitory effect of carbonyl reductase 1 on ovarian cancer growth via tumor necrosis factor receptor signaling.
3/2015Decreased expression of carbonyl reductase 1 promotes ovarian cancer growth and proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihito Yokoyama Research Topics

Disease

45Neoplasms (Cancer)
05/2024 - 04/2003
24Ovarian Neoplasms (Ovarian Cancer)
05/2023 - 01/2007
7Carcinoma (Carcinomatosis)
06/2022 - 04/2003
7Ascites
01/2016 - 01/2007
5Endometrial Neoplasms (Endometrial Cancer)
12/2019 - 04/2003
5Ovarian Epithelial Carcinoma
10/2019 - 09/2013
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023 - 06/2008
4Neoplasm Metastasis (Metastasis)
12/2019 - 03/2015
4Necrosis
10/2019 - 10/2007
4Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2016 - 07/2013
4Carcinosarcoma
06/2015 - 09/2012
3Endometrioid Carcinoma
05/2016 - 03/2014
3Lymphatic Metastasis
11/2014 - 04/2003
2Carcinogenesis
06/2022 - 04/2007
2Thrombocytopenia (Thrombopenia)
01/2021 - 01/2016
2Body Weight (Weight, Body)
01/2021 - 01/2011
2Peripheral Nervous System Diseases (PNS Diseases)
08/2020 - 09/2014
2Disease Progression
08/2017 - 12/2014
2Endometrial Hyperplasia
05/2016 - 04/2003
2Neutropenia
01/2016 - 05/2014
2Peritonitis
01/2016 - 01/2014
2Sarcoma (Soft Tissue Sarcoma)
01/2015 - 12/2014
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
05/2024
1Rupture
10/2023
1Fever (Fevers)
10/2023
1Diabetes Mellitus
05/2023
1Dyslipidemias (Dyslipidemia)
05/2023
1Hypertension (High Blood Pressure)
12/2022
1Intestinal Perforation
12/2022
1Proteinuria
12/2022
1Non-alcoholic Fatty Liver Disease
07/2022
1Erythema
05/2021
1Ileus
08/2020

Drug/Important Bio-Agent (IBA)

9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015 - 04/2003
7PlatinumIBA
12/2022 - 01/2011
6Cisplatin (Platino)FDA LinkGeneric
05/2024 - 05/2011
6Paclitaxel (Taxol)FDA LinkGeneric
05/2023 - 09/2014
5Irinotecan (Camptosar)FDA LinkGeneric
08/2017 - 01/2011
4Carboplatin (JM8)FDA LinkGeneric
05/2023 - 12/2014
4taxaneIBA
08/2020 - 01/2011
4Estrogen ReceptorsIBA
05/2016 - 09/2013
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2011 - 08/2007
4LigandsIBA
08/2011 - 04/2007
3Carbonyl Reductase (NADPH)IBA
10/2019 - 03/2015
31-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2017 - 08/2010
3Clofibric AcidIBA
01/2016 - 04/2007
3Proteins (Proteins, Gene)FDA Link
12/2015 - 01/2014
3Alcohol OxidoreductasesIBA
01/2012 - 04/2007
3ProstaglandinsIBA
08/2011 - 04/2007
3Prostaglandins EIBA
08/2011 - 04/2007
3PPAR gammaIBA
08/2011 - 08/2007
2Etoposide (VP 16)FDA LinkGeneric
05/2024 - 01/2011
2EquolIBA
05/2023 - 07/2022
2Biomarkers (Surrogate Marker)IBA
06/2022 - 08/2017
2niraparibIBA
01/2021 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
10/2019 - 05/2016
2liposomal doxorubicin (Doxil)FDA Link
08/2017 - 05/2014
21-dodecylpyridoxal (PLD)IBA
08/2017 - 05/2014
2delta-aminolevulinic acid methyl esterIBA
06/2017 - 01/2016
2protoporphyrin IXIBA
06/2017 - 01/2016
2nedaplatinIBA
08/2016 - 06/2008
2Small Interfering RNA (siRNA)IBA
05/2016 - 03/2015
2Estrogens (Estrogen)FDA Link
05/2016 - 01/2014
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2016 - 05/2011
2Hormones (Hormone)IBA
01/2014 - 09/2013
2Aromatase InhibitorsIBA
01/2014 - 09/2013
2Cadherins (E-Cadherin)IBA
10/2012 - 12/2011
2Complementary DNA (cDNA)IBA
10/2012 - 01/2012
2Epidermal Growth Factor (EGF)IBA
01/2012 - 08/2010
2milk fat globuleIBA
01/2012 - 08/2010
2Factor VIII (Coagulation Factor VIII)IBA
01/2012 - 08/2010
2ciglitazoneIBA
08/2011 - 08/2007
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2007 - 04/2007
2PPAR alphaIBA
10/2007 - 04/2007
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2007 - 01/2007
2Meloxicam (Mobic)FDA LinkGeneric
08/2007 - 01/2007
1Bleomycin (Blenoxane)FDA LinkGeneric
05/2024
1Indicators and Reagents (Reagents)IBA
05/2024
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2023
1Ampicillin (Omnipen)FDA LinkGeneric
10/2023
1Bevacizumab (Avastin)FDA Link
12/2022
1MicroRNAs (MicroRNA)IBA
06/2022
1Culture MediaIBA
06/2022
1L 644711 (B-3(+))IBA
08/2020

Therapy/Procedure

15Therapeutics
10/2023 - 09/2012
13Drug Therapy (Chemotherapy)
12/2022 - 03/2004
6Radiotherapy
10/2016 - 06/2008
3Lymph Node Excision (Lymph Node Dissection)
08/2020 - 11/2007
3Laparotomy
01/2020 - 05/2011
3Photochemotherapy (Photodynamic Therapy)
06/2017 - 08/2010
2Aftercare (After-Treatment)
12/2019 - 01/2011
2Chemoradiotherapy
08/2016 - 06/2008
2Trachelectomy
08/2015 - 08/2015
2Hysterectomy
12/2014 - 07/2013
1Estrogen Replacement Therapy
05/2024
1Cesarean Section (Caesarean Section)
10/2023
1Blood Component Removal (Apheresis)
05/2021
1Gynecologic Surgical Procedures (Gynecologic Surgery)
08/2020
1Conservative Treatment
08/2020
1Operative Surgical Procedures
08/2020